Key result
Propofol-ketamine and etomidate-midazolam provided similar and acceptable hemodynamic stability during anesthesia induction in patients with left ventricular dysfunction undergoing CABG, with only minor differences in cardiac index and systemic vascular resistance.
Why the study?
Does a propofol-ketamine induction regimen improve hemodynamic stability compared to an etomidate-midazolam regimen in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery?
RCT (n=100)
Single-blind
Computer generated random numbers
No
Does a propofol-ketamine induction regimen improve hemodynamic stability compared to an etomidate-midazolam regimen in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery?
Both propofol-ketamine and etomidate-midazolam combinations provide stable hemodynamics and are safe for anesthesia induction in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery.
Answers are grounded in this paper and cite their sources.
Both regimens offer acceptable hemodynamic stability for induction in LV dysfunction CABG patients; confirms equivalence and supports individualized choice.
BACKGROUND: Various methods have been suggested to prevent hemodynamic instability caused by propofol and adverse effects caused by etomidate induction. The current study evaluated hemodynamic effects of propofol-ketamine mixture in comparison to etomidate-midazolam mixture during anesthesia induction. OBJECTIVES: The aim of this study was to evaluate the hemodynamic effects of etomidate-midazolam by comparing it with propofol-ketamine for the induction of anesthesia in patients with left ventricular dysfunction undergoing coronary artery bypass graft surgery. PATIENTS AND METHODS: One-hundred patients aged between 40 and 65 with coronary artery disease and low ejection fraction scheduled for elective coronary artery bypass surgery participated in this study. The patients were randomly allotted to one of the two groups to receive either propofol-ketamine or etomidate-midazolam combination. Two groups were compared for pain on injection and myoclonus, Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP), Cardiac Index (CI) and Systemic Vascular Resistance (SVR), before and one minute after induction of anesthesia, and one, three and five minutes after intubation. RESULTS: Incidence of pain on injection (2 - 4%) and myoclonus (10%) was less in both groups. The hemodynamic response was similar in the two groups for all variables over the time interval, except for CI at one and three minutes after intubation (P = 0.024 and P = 0.048, respectively), and SVR in five minutes after intubation (P = 0.009), with differences being statistically significant. CONCLUSIONS: Both anesthetic regimens were acceptable for induction in patients with coronary artery disease and left ventricular dysfunction undergoing coronary artery bypass graft surgery.
No takes yet. Share an insight, caveat, or question.
Aghdaii et al. (2015) conducted an RCT in Coronary artery disease with left ventricular dysfunction (n=100). Propofol-ketamine vs. Etomidate-midazolam (0.2 mg/kg etomidate and 0.06 mg/kg midazolam) was evaluated on Hemodynamic responses (HR, SBP, DBP, MAP, CI, SVR) during anesthesia induction and intubation. Propofol-ketamine and etomidate-midazolam provided similar and acceptable hemodynamic stability during anesthesia induction in patients with left ventricular dysfunction undergoing CABG, with only minor differences in cardiac index and systemic vascular resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: